Login / Signup

Author Correction: Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial.

Maria Vittoria DieciGiancarlo BisagniStefania BartoliniAntonio FrassoldatiRoberto ViciniSara BalduzziRoberto D'amicoPierfranco ConteValentina Guarneri
Published in: NPJ breast cancer (2023)
Keyphrases
  • phase iii
  • free survival
  • open label
  • clinical trial
  • double blind
  • placebo controlled
  • phase ii
  • early stage
  • study protocol
  • stem cells
  • bone marrow
  • mesenchymal stem cells